La cadena de opciones muestra datos clave de las opciones de acciones de Dave a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Dave..

Dave (NASDAQ:DAVE) Bolsa, Cadena de Opciones

DAVE INC

Dave

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

DAVE

ROST

Wall Street anticipa ganancias de Target, AutoZone y Best Buy, mientras que las acciones de Dave y Ross Stores se mueven en preapertura.

Acciones en el foco este martes: Target (TGT), AutoZone (AZO), Dave (DAVE), Best Buy (BBY) y Ross Stores (ROST)

Equities

Small Cap

COST

KULR

MSTR

NVDA

PLTR

QMCO

RCAT

SEZL

Acciones de pequeña capitalización lideran 2024 con rendimientos sorprendentes. Descubre qué impulsó su crecimiento y quiénes destacan.

Cómo las acciones de pequeña capitalización están venciendo a gigantes del mercado en medio de un rally alcista

Dave Inc

Dave & Buster's Entertainment, Inc. - Common Stock

Dave & Buster's Entertainment Inc

During the last three months, 15 analysts shared their evaluations of Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Dave, presenting an average target of $156.73, a high estimate of $239.00, and a low estimate of $110.00. Marking an increase of 17.73%, the current average surpasses the previous average price target of $133.13. 
<img src="https://www.benzinga.com/files/images/story/2025/1748379733_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Dave among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hal Goetsch</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$239.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$229.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jacob Stephan</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Buy</td>
<td>$177.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$202.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$179.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Jacob Stephan</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Buy</td>
<td>$118.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Hal Goetsch</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$142.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$145.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Dave. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dave compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Dave's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DAVE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Dave analyst ratings.</a>
<h2>Delving into Dave's Background</h2>
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.
<h3>Financial Milestones: Dave's Journey</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Dave displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 46.65%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Dave's net margin excels beyond industry benchmarks, reaching 26.68%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 15.06%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Dave's ROA excels beyond industry benchmarks, reaching 9.37%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.38.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Dave Stock

B. Riley Securities analyst Hal Goetsch maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $206 to $239.

Price Target

B. Riley Securities Maintains Buy on Dave, Raises Price Target to $239

WIIM

Dave shares are trading higher after Benchmark raised its price target on the stock from $202 to $229 and maintained a Buy rating.

Benchmark analyst Mark Palmer maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $202 to $229.

Benchmark Maintains Buy on Dave, Raises Price Target to $229

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol class="wp-block-list">
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares jumped 72.40%  after the company inked a strategic deal with Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to deploy Pony.ai&#8217;s <a href="https://www.benzinga.com//node/45225030" target="_blank" rel="noreferrer noopener">robotaxis onto the Uber platform</a>.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) shares increased 59.68% after the company reported strong first-quarter results and<a href="https://www.benzinga.com//node/45280986" target="_blank" rel="noreferrer noopener"> raised its FY25 sales guidance</a>. Several analysts <a href="https://www.benzinga.com/quote/dave/analyst-ratings" target="_blank" rel="noreferrer noopener">boosted the price forecast</a>.</li>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) stock escalated 56.29%  after the company reported better-than-expected first quarter results and <a href="https://www.benzinga.com//node/45266202" target="_blank" rel="noreferrer noopener">raised its FY25 guidance</a>.</li>
<li>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) shares were up 57.65% after the company reported a year-over-year increase in first-quarter adjusted EPS results and<a href="https://www.benzinga.com//node/45267567" target="_blank" rel="noreferrer noopener"> better-than-expected sales results</a>.</li>
<li>D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) stock rose 40.20% after the company posted record first-quarter 2025 financial results and highlighted major technical milestones <a href="https://www.benzinga.com//node/45294899" target="_blank" rel="noreferrer noopener">in commercial quantum computing</a>. Needham analyst Quinn Bolton maintained a Buy rating and raised the <a href="https://www.benzinga.com/quote/qbts/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast from $8.5 to $13</a>.</li>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) stock increased 31.62% after the company reported better-than-expected first-quarter earnings and increased <a href="https://www.benzinga.com//node/45320549" target="_blank" rel="noreferrer noopener">its share repurchase program.</a></li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) stock rose 29.62% after the company reported better-than-expected financial results and issued FY25<a href="https://www.benzinga.com//node/45246795" target="_blank" rel="noreferrer noopener"> sales guidance above estimates</a>.</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) shares gained 28.71% after the company reported an April Bitcoin production increase of 45.6% to <a href="https://www.benzinga.com//node/45313832" target="_blank" rel="noreferrer noopener">166 BTC on Sealminer deployment</a>.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) stock gained 28.67% last week after reporting better-than-expected <a href="https://www.benzinga.com//node/45268589" target="_blank" rel="noreferrer noopener">Q1 financial results</a>. The stock also reacted to a report suggesting Republican lawmakers support tax credits in former President Biden&#8217;s Inflation Reduction Act legislation.</li>
</ol>
Image Via Shutterstock

Mid Cap

Movers

BTDR

LYFT

OSCR

PONY

QBTS

UBER

Pony AI, Lyft And Sunrun Are Among Top 9 Mid-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio?

In the last three months, 13 analysts have published ratings on Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $144.85, a high estimate of $202.00, and a low estimate of $110.00. Observing a 18.51% increase, the current average has risen from the previous average price target of $122.23. 
<img src="https://www.benzinga.com/files/images/story/2025/1746817259_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Dave. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jacob Stephan</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Buy</td>
<td>$177.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$202.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$179.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Jacob Stephan</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Buy</td>
<td>$118.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Hal Goetsch</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$142.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$145.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Dave. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dave compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Dave's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Dave's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DAVE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Dave analyst ratings.</a>
<h2>Get to Know Dave Better</h2>
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.
<h3>Dave's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Dave's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 37.91% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Dave's net margin excels beyond industry benchmarks, reaching 16.67%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Dave's ROE excels beyond industry benchmarks, reaching 9.92%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Dave's ROA stands out, surpassing industry averages. With an impressive ROA of 5.88%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.41, Dave adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Dave's Future

Dave shares are trading higher after the company reported strong Q1 results and raised its FY25 sales guidance.

JMP Securities analyst Devin Ryan maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Market Outperform and raises the price target from $125 to $200.

JMP Securities Maintains Market Outperform on Dave, Raises Price Target to $200

Lake Street analyst Jacob Stephan maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $118 to $177.

Lake Street Maintains Buy on Dave, Raises Price Target to $177

Benchmark analyst Mark Palmer maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $145 to $202.

Benchmark Maintains Buy on Dave, Raises Price Target to $202

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Needham cut MKS Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) price target from $145 to $140. Needham analyst James Ricchiuti maintained a Buy rating. MKS Instruments shares closed at $77.29 on Thursday. <a href="https://www.benzinga.com/quote/MKSI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. slashed the price target for Draganfly Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPRO#NASDAQ">DPRO</a>) from $7 to $5. HC Wainwright &amp; Co. analyst Scott Buck maintained a Buy rating. Draganfly shares closed at $1.89 on Thursday. <a href="https://www.benzinga.com/quote/DPRO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity raised Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) price target from $130 to $179. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Dave shares closed at $152.73 on Thursday. <a href="https://www.benzinga.com/quote/DAVE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Chardan Capital increased the price target for Oculis Holding AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCS#NASDAQ">OCS</a>) from $28 to $33. Chardan Capital analyst Daniil Gataulin maintained a Buy rating. Oculis Holding shares closed at $18.70 on Thursday. <a href="https://www.benzinga.com/quote/OCS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group slashed the price target for Vital Farms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>) from $52 to $46. Telsey Advisory Group analyst Sarang Vora maintained an Outperform rating. Vital Farms shares closed at $32.57 on Thursday. <a href="https://www.benzinga.com/quote/VITL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) price target from $15 to $7. JP Morgan analyst Robbie Marcus downgraded the stock from Neutral to Underweight. CVRx shares settled at $7.78 on Thursday. <a href="https://www.benzinga.com/quote/CVRX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham slashed CarGurus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) price target from $45 to $39. Needham analyst Chris Pierce maintained a Buy rating. CarGurus shares closed at $27.95 on Thursday. <a href="https://www.benzinga.com/quote/CARG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut International Paper Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) price target from $45 to $40. Wells Fargo analyst Gabe Hajde downgraded the stock from Equal-Weight to Underweight. International Paper shares closed at $44.92 on Thursday.  <a href="https://www.benzinga.com/quote/IP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. slashed the price target for Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) from $32 to $20. HC Wainwright &amp; Co. analyst Joseph Pantginis maintained a Buy rating. Iovance Biotherapeutics shares settled at $3.17 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this</a><a href="https://www.benzinga.com/quote/IOVA/analyst-ratings"> </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">stock</a>.</li>
<li>Wells Fargo cut Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) price target from $205 to $180. Wells Fargo analyst Gabe Hajde downgraded the stock from Overweight to Equal-Weight. Packaging Corporation shares closed at $183.42 on Thursday. <a href="https://www.benzinga.com/quote/PKG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying DAVE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09075444/image-104-1024x577.png" alt="" class="wp-image-910007" style="width:580px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09075444/image-104-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09075444/image-104-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09075444/image-104-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09075444/image-104.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45285413/top-3-financial-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Financial Stocks Which Could Rescue Your Portfolio This Month</a> </li>
</ul>
Photo via Shutterstock

CARG

CVRX

DPRO

IOVA

MKSI

VITL

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday

Canaccord Genuity analyst Joseph Vafi maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $130 to $179.

Canaccord Genuity Maintains Buy on Dave, Raises Price Target to $179

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of Groupon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) rose sharply during Thursday's session after the company reported <a href="https://in.benzinga.com/news/earnings/25/05/45285163/groupon-q1-billings-sees-double-digit-growth-in-north-america-guides-q2-above-consensus">better-than-expected first-quarter financial results.</a>
The company reported revenue of $117.2 million, beating estimates of $115.5 million, according to Benzinga Pro. Groupon reported an EPS of 18 cents, versus estimates for a loss of 11 cents.
Groupon shares jumped 26.3% to $21.45 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>SunOpta Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) shares jumped 41.3% to $6.40 after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance above estimates. Additionally, the company announced a $25 million share repurchase program.</li>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) gained 36.5% to $72.00 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) rose 33.3% to $143.75 after the company reported strong first-quarter results and raised its FY25 sales guidance.</li>
<li>LegalZoom.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) gained 30% to $9.42 after the company reported better-than-expected first-quarter sales results and issued second-quarter sales guidance with its midpoint above estimates. Also, the company issued FY25 sales guidance above estimates.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 29% to $245.00.</li>
<li>QuidelOrtho Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) gained 29% to $33.30 following upbeat quarterly earnings.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) gained 24% to $9.86 after the company reported better-than-expected first-quarter financial results.</li>
<li>D-Wave Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NASDAQ">QBTS</a>) rose 22% to $8.41 after the company reported better-than-expected quarterly financial results.</li>
<li>Revolution Medicines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) jumped 15.5% to $43.39 following quarterly results.</li>
<li>AppLovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) gained 15.5% to $350.42 after the company reported better-than-expected first-quarter financial results.</li>
<li>EPAM Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) rose 14.8% to $182.95 after the company reported better-than-expected first-quarter financial results and issued second-quarter adjusted EPS guidance above estimates. Also, the company raised its FY25 guidance.</li>
<li>Watts Water Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) gained 10.7% to $234.35 following strong quarterly results.</li>
<li>SharkNinja, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) surged 10.1% to $89.36 after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance above estimates.</li>
<li>Axon Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) rose 9.6% to $659.40 after the company reported better-than-expected first-quarter financial results and raised FY25 sales guidance.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 9.1% to $282.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) jumped 7.5% to $9.20 following quarterly results.</li>
<li>Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>) gained 7.6% to $9.26 after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
<li>MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) gained 7% to $2,418.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) rose 5.9% to $242.05 following upbeat quarterly results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45284390/how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

ALVO

AXON

CVNA

EPAM

GRPN

MELI

PAYC

QDEL

RVMD

STKL

VTRS

Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday

Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) raises FY2025 sales outlook from $415.00 million-$435.00 million to $460.00 million-$475.00 million vs $499.51 million estimate.

Guidance

Dave Raises FY2025 Sales Guidance from $415.00M-$435.00M to $460.00M-$475.00M vs $499.51M Est

Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) reported quarterly earnings of $2.48 per share which beat the analyst consensus estimate of $0.79 by 213.92 percent. This is a 300 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $108.00 million which beat the analyst consensus estimate of $100.80 million by 7.14 percent. This is a 46.74 percent increase over sales of $73.60 million the same period last year.

Earnings Beats

Dave Q1 Adj. EPS $2.48 Beats $0.79 Estimate, Sales $108.00M Beat $100.80M Estimate

AAOI

ABCL

ABEV

ACIC

ACIW

ACMR

ACTG

AFRM

AKAM

AKBA

ALGM

ALIT

ALRM

ALXO

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AMPX

AMTX

APPN

APYX

AQMS

ARGX

ARHS

ARKO

ARLO

ASPN

ASTH

Adtalem Global Education Inc. Common Stock

ATGE

ATHM

ATUS

AUTL

AVAH

AVPT

AXGN

BAER

BBDC

BIGC

BILL

BIRD

BlackSky Technology Inc. Class A Common Stock

BKSY

BLFS

BLND

CARS

CBLL

CBUS

CCEC

CCOI

CCRD

CDTX

CION

CLAR

CLFD

CLNE

CLSK

CMPS

CMRE

CODX

COIN

COLD

COLL

COMP

CRNX

CRON

CROX

CRVS

CTEV

CTKB

CTLP

DCGO

DCTH

DIOD

DKNG

Earnings Scheduled For May 8, 2025

ATLC

CACC

ECPG

GDOT

KSPI

MOGO

NAVI

NRDS

PRAA

WRLD

Shares of consumer finance companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Digital banking platform, Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) has been on a fiery streak in recent months, up 121% since Nov. 2024. However, according to leading Wall Street analysts, the California-based bank is only just getting started, with plenty of growth in the years ahead.
What Happened: Analysts see strong upside in the stock, with almost all rating it a &#8216;Buy&#8217; or &#8216;Overweight&#8217;, with an average consensus Price Target of $128, representing an upside of 55%. On the high end, the Price Target stands at $145, or a 75% growth from current levels.
See More: <a href="https://www.benzinga.com/25/03/44577203/tom-lee-says-markets-are-deeply-oversold-expects-bitcoin-to-lead-rebound-as-investors-fear-trumps-tariff-impact">Tom Lee Says Markets Are &#8216;Deeply Oversold,&#8217; Expects Bitcoin To Lead Rebound As Investors Fear Trump&#8217;s Tariff Impact</a>
B.Riley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) raised its outlook on the stock following Dave&#8217;s fourth quarter results when it blew past estimates while forecasting growth of 22% for 2025. In addition to the company&#8217;s guidance, the analyst cited its &#8216;robust business momentum and expense leverage&#8217; while issuing its Price Target.
Another analyst, Canaccord adds that during a period of growing concerns surrounding consumer spending and credit at fintech companies, Dave&#8217;s performance was rather remarkable. It goes on to admire its tech-enabled operating model, resulting in an impressive gross profit margin of 60%, and allowing it to <a href="https://www.benzinga.com/25/01/43401752/daves-innovative-approach-has-led-to-impressive-financial-growth-says-analyst">profit even with small customer account balances</a>. 
Experts and analysts further highlight that despite the stock&#8217;s rally over the past 5 months, it is still undervalued, trading at just under 14 times forward earnings. 
What It Means: This means that the stock has plenty of room to grow, and for investors, this is one of the few fintech opportunities they can get in early, which is profitable, has a proven model, and strong moats, such as its AI underwriting, which keeps getting better with time and more data.
Dave currently has over 10 million users, out of 80 million consumers in the US alone who are in need of financial stability, and 100s of millions more across the globe. 
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="726" height="244" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01043447/Screenshot-2025-04-01-at-2.04.27-PM.png" alt="" class="wp-image-850662" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01043447/Screenshot-2025-04-01-at-2.04.27-PM.png 726w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01043447/Screenshot-2025-04-01-at-2.04.27-PM-300x101.png 300w" sizes="(max-width: 726px) 100vw, 726px" /></figure>
According to the Benzinga Edge, Dave scores an impressive 98th percentile on momentum, and while it lags on certain other fronts, this implies strong near-term upside potential. For a more comprehensive analysis, consider checking out <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44579268/who-is-peter-thiels-protege-michael-kratsios-now-leading-trumps-ai-strategy-amid-rising-tech-tensions-with-china">Who Is Peter Thiel&#8217;s Protégé, Michael Kratsios, Now Leading Trump&#8217;s AI Strategy Amid Rising Tech Tensions With China?</a></li>
</ul>
Photo courtesy: Shutterstock

RILY

Wall Street Predicts More Growth For Digital Banking Platform Dave: Here's What You Need To Know

ALLY

ARES

Bakkt Holdings, Inc. Class A Common Stock

BKKT

ERIE

HLNE

HOOD

KNSL

LMND

SCHW

SEIC

SOFI

STEP

Shares of financial stocks are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.

Legal

Press Releases

Dave Inc. Investor News: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm Encourages Dave Inc. Investors to Inquire About Securities Class Action Investigation - DAVE

Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Bragar Eagel & Squire, P.C. Is Investigating Dave, RH, Solaris, and XP and Encourages Investors to Contact the Firm

Dave Donates $1 Million to Los Angeles Regional Food Bank to Support Community Recovery Efforts

Valneva SE Company Investigated by the Portnoy Law Firm

Dave to Host First Quarter 2025 Conference Call on May 8, 2025 at 8:30 a.m. ET

Comments

Dave

Dave (DAVE) Opciones

Dave (NASDAQ:DAVE) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL